Trial Profile
Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2023
Price :
$35
*
At a glance
- Drugs Fluticasone furoate (Primary)
- Indications Seasonal allergic rhinitis
- Focus Pharmacodynamics
- 15 Jun 2012 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 15 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 13 May 2009 Planned end date changed from Jul 2009 to Sep 2009 as reported by ClinicalTrials.gov.